Tag: Evident Vascular

Evident Vascular Receives FDA Clearance for High-Fidelity AI Powered IVUS Imaging Platform

SAN JOSE, Calif.–(BUSINESS WIRE)–Evident Vascular, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident Vascular® Guidance System and Evident® peripheral imaging catheters. The Evident Vascular Guidance System is intended for ultrasound examination of intravascular pathology during peripheral vascular interventions. The Evident platform is designed to transform the IVUS imaging experience by bringing together high-fidelity imaging, purpose-built AI, an

Evident Vascular Raises Series B Financing to Advance AI-Powered Intravascular Ultrasound Platform Technology

Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch SAN JOSE, Calif.–(BUSINESS WIRE)–Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence, today announced the successful closing of its Series B financing with new […]

Evident Vascular Welcomes Scott R. Ward to its Board of Directors

SAN JOSE, Calif.–(BUSINESS WIRE)–Evident Vascular, Inc., a medical technology startup backed by Vensana Capital® developing an AI-powered next-generation intravascular ultrasound (IVUS) platform, is pleased to announce the appointment of Scott R. Ward to its Board of Directors. “We are thrilled to welcome Scott to the Evident Vascular Board” Post this […]

Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Intravascular Imaging Platform

SAN JOSE, Calif.–(BUSINESS WIRE)–Evident Vascular, Inc., a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced today that it has launched with a $35 million Series A financing from Vensana Capital®. “Legacy IVUS platforms were originally designed primarily for […]